Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"

Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"

FromInvestors' Chronicle


Dr Paul Jourdan: "Lots of people love to knock Aim. I'm absolutely not in that camp"

FromInvestors' Chronicle

ratings:
Length:
38 minutes
Released:
Oct 20, 2021
Format:
Podcast episode

Description

Paul Jourdan, CEO of Amati Global Investors, tells Christopher Akers why he thinks the Alternative Investment Market is an asset of national importance and shares his thoughts on overpricing in "the year of IPOs". He explains Amati's approach to ESG and discusses the stocks that have been important for them over the last year. Hosted on Acast. See acast.com/privacy for more information.
Released:
Oct 20, 2021
Format:
Podcast episode

Titles in the series (100)

Concerned with QE's effects on equity valuations? Looking for ideas for your Isa? Or just plain confused by the stock market? Each week, the Investors Chronicle picks apart the latest news for companies, markets and funds in our regular magazine podcasts. Subscribe for these, along with CEO interviews, company-specific shows and special in-depth discussions on big market themes. Hosted on Acast. See acast.com/privacy for more information.